New ultrasound 'Helmet' trial aims to zap brain cancer
Disease control
Recruiting now
This study is testing if a new, non-invasive ultrasound device, used with a light-sensitive drug, can help control a fast-growing brain cancer called glioblastoma. After standard surgery and chemo-radiation, about 100 patients will be randomly assigned to receive either the real …
Phase: PHASE2 • Sponsor: Alpheus Medical, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC